1. Home
  2. GDRX vs CADL Comparison

GDRX vs CADL Comparison

Compare GDRX & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$3.45

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$12.87

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDRX
CADL
Founded
2011
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
GDRX
CADL
Price
$3.45
$12.87
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$3.66
$19.00
AVG Volume (30 Days)
1.7M
1.3M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
58.62
EPS
0.03
N/A
Revenue
$796,853,000.00
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.38
N/A
P/E Ratio
$118.67
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.77
$4.35
52 Week High
$5.61
$13.82

Technical Indicators

Market Signals
Indicator
GDRX
CADL
Relative Strength Index (RSI) 53.59 67.55
Support Level $2.54 $4.84
Resistance Level $3.89 N/A
Average True Range (ATR) 0.21 0.72
MACD -0.02 0.21
Stochastic Oscillator 46.10 75.74

Price Performance

Historical Comparison
GDRX
CADL

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: